JP2016028085A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016028085A5 JP2016028085A5 JP2015182821A JP2015182821A JP2016028085A5 JP 2016028085 A5 JP2016028085 A5 JP 2016028085A5 JP 2015182821 A JP2015182821 A JP 2015182821A JP 2015182821 A JP2015182821 A JP 2015182821A JP 2016028085 A5 JP2016028085 A5 JP 2016028085A5
- Authority
- JP
- Japan
- Prior art keywords
- water
- darunavir hydrate
- crystalline
- hydrate
- darunavir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JKQULTRRXSDLJN-VBTXLZOXSA-N [(3as,4r,6ar)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] n-[(2s,3r)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate;hydrate Chemical compound O.C([C@@H]([C@H](O)CN(CC(C)C)S(=O)(=O)C=1C=CC(N)=CC=1)NC(=O)O[C@@H]1[C@@H]2CCO[C@@H]2OC1)C1=CC=CC=C1 JKQULTRRXSDLJN-VBTXLZOXSA-N 0.000 claims 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- 239000007787 solid Substances 0.000 claims 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- 238000003756 stirring Methods 0.000 claims 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 2
- 208000031886 HIV Infections Diseases 0.000 claims 2
- 208000037357 HIV infectious disease Diseases 0.000 claims 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- 238000002441 X-ray diffraction Methods 0.000 claims 2
- 239000003125 aqueous solvent Substances 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 2
- KBPYLZJQXANQPM-WLUDYRNVSA-N [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] hydrogen carbonate 1-methylpyrrolidine-2,5-dione Chemical compound CN1C(=O)CCC1=O.O1CC[C@H]2[C@@H](OC(=O)O)CO[C@H]21 KBPYLZJQXANQPM-WLUDYRNVSA-N 0.000 claims 1
- 239000013078 crystal Substances 0.000 claims 1
- CJBJHOAVZSMMDJ-HEXNFIEUSA-N darunavir Chemical compound C([C@@H]([C@H](O)CN(CC(C)C)S(=O)(=O)C=1C=CC(N)=CC=1)NC(=O)O[C@@H]1[C@@H]2CCO[C@@H]2OC1)C1=CC=CC=C1 CJBJHOAVZSMMDJ-HEXNFIEUSA-N 0.000 claims 1
- 229960005107 darunavir Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN33MU2010 | 2010-01-05 | ||
| IN33/MUM/2010 | 2010-01-05 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012546497A Division JP2013516397A (ja) | 2010-01-05 | 2010-10-06 | ダルナビルの多形及びその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016028085A JP2016028085A (ja) | 2016-02-25 |
| JP2016028085A5 true JP2016028085A5 (enExample) | 2016-04-07 |
Family
ID=43125640
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012546497A Pending JP2013516397A (ja) | 2010-01-05 | 2010-10-06 | ダルナビルの多形及びその製造方法 |
| JP2015182821A Pending JP2016028085A (ja) | 2010-01-05 | 2015-09-16 | ダルナビルの多形及びその製造方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012546497A Pending JP2013516397A (ja) | 2010-01-05 | 2010-10-06 | ダルナビルの多形及びその製造方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20130029945A1 (enExample) |
| EP (1) | EP2521728B1 (enExample) |
| JP (2) | JP2013516397A (enExample) |
| KR (1) | KR20120123077A (enExample) |
| AU (1) | AU2010340799B2 (enExample) |
| CA (1) | CA2785998A1 (enExample) |
| NZ (1) | NZ600994A (enExample) |
| WO (1) | WO2011083287A2 (enExample) |
| ZA (1) | ZA201204365B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2503551T5 (es) | 2002-05-16 | 2021-10-28 | Janssen Sciences Ireland Unlimited Co | Formas pseudopolimórficas de un inhibidor de la proteasa de VIH |
| US8921415B2 (en) | 2009-01-29 | 2014-12-30 | Mapi Pharma Ltd. | Polymorphs of darunavir |
| EP2528923B1 (en) | 2010-01-28 | 2014-07-30 | Mapi Pharma Limited | Process for the preparation of darunavir and darunavir intermediates |
| WO2013114382A1 (en) | 2011-12-05 | 2013-08-08 | Mylan Laboratories Ltd | Crystalline darunavir |
| CN103509031B (zh) * | 2012-06-20 | 2016-04-27 | 上海迪赛诺药业有限公司 | 制备达芦那韦无定形物的方法 |
| ES2848216T3 (es) | 2012-07-24 | 2021-08-05 | Laurus Labs Ltd | Un proceso para la preparación de Darunavir |
| WO2016092525A1 (en) | 2014-12-12 | 2016-06-16 | Lupin Limited | Darunavir n-propanol solvate and process for preparation thereof |
| CN106854212A (zh) * | 2015-12-08 | 2017-06-16 | 浙江九洲药业股份有限公司 | 一种达芦那韦无定型的制备方法 |
| CN106242307A (zh) * | 2016-08-11 | 2016-12-21 | 京东方科技集团股份有限公司 | 用于强化制品的边缘的方法、玻璃及显示装置 |
| US10407438B2 (en) | 2016-10-27 | 2019-09-10 | Gilead Sciences, Inc. | Crystalline forms of darunavir |
| CN108727401A (zh) * | 2017-04-20 | 2018-11-02 | 盐城迪赛诺制药有限公司 | 达鲁那韦新晶型及其制备方法和应用 |
| CN108794498A (zh) * | 2017-05-03 | 2018-11-13 | 江苏瑞科医药科技有限公司 | 一种达芦那韦无定型的制备方法 |
| CN109053753A (zh) * | 2018-08-05 | 2018-12-21 | 浙江大学 | 一种制备达卢那韦二水合物晶型的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7669794A (en) | 1993-08-24 | 1995-03-21 | G.D. Searle & Co. | Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors |
| JP4776775B2 (ja) | 1998-06-23 | 2011-09-21 | アメリカ合衆国 | Ｈｉｖ感染哺乳動物を治療するための医薬組成物 |
| ES2503551T5 (es) * | 2002-05-16 | 2021-10-28 | Janssen Sciences Ireland Unlimited Co | Formas pseudopolimórficas de un inhibidor de la proteasa de VIH |
| DE602004021640D1 (de) | 2003-12-23 | 2009-07-30 | Tibotec Pharm Ltd | Verfahren zur herstellung von (1s,2r)-3-ää(4-aminophenyl)sulfonylü(isobutyl)aminoü-1-benzyl-2-hydroxypropylcarbamidsäure-(3r,3as,6ar)-hexahydrofuroä2,3-büfuran-3-ylester |
| WO2011048604A2 (en) * | 2009-09-17 | 2011-04-28 | Matrix Laboratories Limited | An improved process for the preparation of darunavir |
| ES2546866T3 (es) * | 2009-12-16 | 2015-09-29 | Hetero Research Foundation | Polimorfos de darunavir |
-
2010
- 2010-10-06 AU AU2010340799A patent/AU2010340799B2/en not_active Ceased
- 2010-10-06 JP JP2012546497A patent/JP2013516397A/ja active Pending
- 2010-10-06 NZ NZ600994A patent/NZ600994A/en not_active IP Right Cessation
- 2010-10-06 KR KR1020127020434A patent/KR20120123077A/ko not_active Ceased
- 2010-10-06 US US13/519,817 patent/US20130029945A1/en not_active Abandoned
- 2010-10-06 WO PCT/GB2010/001874 patent/WO2011083287A2/en not_active Ceased
- 2010-10-06 EP EP10765473.3A patent/EP2521728B1/en not_active Not-in-force
- 2010-10-06 CA CA2785998A patent/CA2785998A1/en not_active Abandoned
-
2012
- 2012-06-14 ZA ZA2012/04365A patent/ZA201204365B/en unknown
-
2015
- 2015-01-30 US US14/610,349 patent/US20150141383A1/en not_active Abandoned
- 2015-09-16 JP JP2015182821A patent/JP2016028085A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018024682A5 (enExample) | ||
| RU2018101363A (ru) | Кристаллическая форма свободного основания лорлатиниба | |
| JP2013237682A5 (enExample) | ||
| JP2013528182A5 (enExample) | ||
| JP2014169319A5 (enExample) | ||
| WO2014209841A3 (en) | Compounds for treating spinal muscular atrophy | |
| RU2017131862A (ru) | КРИСТАЛЛИЧЕСКИЕ ФОРМЫ (S)-5-БЕНЗИЛ-N-(5-МЕТИЛ-4-ОКСО-2,3,4,5-ТЕТРАГИДРОБЕНЗО[b][1,4]ОКСАЗЕПИН-3-ИЛ)-4H-1,2,4-ТРИАЗОЛ-3-КАРБОКСАМИДА | |
| NZ600994A (en) | Darunavir polymorph and process for preparation thereof | |
| JP2018520205A5 (enExample) | ||
| JP2014501766A5 (enExample) | ||
| HRP20171151T1 (hr) | Inhibitori cdc7 | |
| HRP20121028T1 (hr) | Kristalni oblici febuksostata | |
| JP2015500331A5 (enExample) | ||
| JP2015528812A5 (enExample) | ||
| RU2015156142A (ru) | Бисульфат ингибитора янус-киназы (jak) и способ его получения | |
| ME02838B (me) | 3,4-dihidroizokinolin-2(1h)-ilni spojevi | |
| JP2011522827A5 (enExample) | ||
| TW201613931A (en) | Form crystal of bisulfate of janus kinase (JAK) inhibitor and preparation method thereof | |
| JP2015129106A5 (enExample) | ||
| JP2014098049A5 (enExample) | ||
| RU2022109286A (ru) | Кристаллическая форма гидрата свободного основания лорлатиниба | |
| JP2015516425A5 (enExample) | ||
| JP2016510767A5 (enExample) | ||
| JP2013520488A5 (enExample) | ||
| JP2017535510A5 (enExample) |